Novel strategies for anti-aging drug discovery

References

• Niccoli T, Partridge L. Ageing as a risk factor for disease. Curr Biol. 2012;22:R741–R752.
   PubMed Web of Science ®Google Scholar
• Hazzard WR, Halter JB, editors. Hazzard’s geriatric medicine and gerontology. 6th ed. New York, NY: McGraw-Hill Medical; 2009.
   Google Scholar
• López-Otín C, Blasco MA, Partridge L, et al. The hallmarks of aging. Cell. 2013;153:1194–1217.
   PubMed Web of Science ®Google Scholar
• Klass MR. A method for the isolation of longevity mutants in the nematode Caenorhabditis elegans and initial results. Mech Ageing Dev. 1983;22:279–286.
   PubMed Web of Science ®Google Scholar
• Tatar M. The endocrine regulation of aging by insulin-like signals. Science. 2003;299:1346–1351.
   PubMed Web of Science ®Google Scholar
• Johnson SC, Rabinovitch PS, Kaeberlein M. mTOR is a key modulator of ageing and age-related disease. Nature. 2013;493:338–345.
   PubMed Web of Science ®Google Scholar
• Salminen A, Kaarniranta K. AMP-activated protein kinase (AMPK) controls the aging process via an integrated signaling network. Ageing Res Rev. 2012;11:230–241.
   PubMed Web of Science ®Google Scholar
• Longo VD, Kennedy BK. Sirtuins in aging and age-related disease. Cell. 2006;126:257–268.
   PubMed Web of Science ®Google Scholar
• Most J, Tosti V, Redman LM, et al. Calorie restriction in humans: an update. Ageing Res Rev [Internet]. 2016 [ cited 2017 Feb 17]. Available from http://linkinghub.elsevier.com/retrieve/pii/S1568163716301830
   PubMedGoogle Scholar
• Sun L, Sadighi Akha AA, Miller RA, et al. Life-span extension in mice by preweaning food restriction and by methionine restriction in middle age. J Gerontol A Biol Sci Med Sci. 2009;64A:711–722.
   Web of Science ®Google Scholar
• Mattison JA, Colman RJ, Beasley TM, et al. Caloric restriction improves health and survival of rhesus monkeys. Nat Commun. 2017;8:14063.
   PubMed Web of Science ®Google Scholar
• Harman D. Free-radical theory of aging: increasing the functional life span. Ann N Y Acad Sci. 1994;717:1–15.
   PubMed Web of Science ®Google Scholar
• Walsh ME, Shi Y, van Remmen H. The effects of dietary restriction on oxidative stress in rodents. Free Radic Biol Med. 2014;66:88–99.
   PubMed Web of Science ®Google Scholar
• Canto C, Auwerx J. Calorie restriction: is AMPK a key sensor and effector? Physiology. 2011;26:214–224.
   PubMed Web of Science ®Google Scholar
• Mitchell SE, Delville C, Konstantopedos P, et al. The effects of graded levels of calorie restriction: II. Impact of short term calorie and protein restriction on circulating hormone levels, glucose homeostasis and oxidative stress in male C57BL/6 mice. Oncotarget. 2015;6:23213–23237.
   PubMed Web of Science ®Google Scholar
• Yang F, Chu X, Yin M, et al. mTOR and autophagy in normal brain aging and caloric restriction ameliorating age-related cognition deficits. Behav Brain Res. 2014;264:82–90.
   PubMed Web of Science ®Google Scholar
• Imai S, Guarente L. It takes two to tango: NAD+ and sirtuins in aging/longevity control. Npj Aging Mech Dis. 2016;2:16017.
   PubMed Web of Science ®Google Scholar
• Dirks AJ, Leeuwenburgh C. Caloric restriction in humans: potential pitfalls and health concerns. Mech Ageing Dev. 2006;127:1–7.
   PubMed Web of Science ®Google Scholar
• Mattson MP, Longo VD, Harvie M. Impact of intermittent fasting on health and disease processes. Ageing Res Rev [Internet]. 2016 cited 2017 May 7. Available from http://linkinghub.elsevier.com/retrieve/pii/S1568163716302513
   Google Scholar
• Martin B, Mattson MP, Maudsley S. Caloric restriction and intermittent fasting: two potential diets for successful brain aging. Ageing Res Rev. 2006;5:332–353.
   PubMed Web of Science ®Google Scholar
• Ingram DK, Roth GS. 2015. Calorie restriction mimetics: can you have your cake and eat it, too? Ageing Res Rev. 20:46–62.
   PubMed Web of Science ®Google Scholar
• Semba RD, Nicklett EJ, Ferrucci L. Does accumulation of advanced glycation end products contribute to the aging phenotype? J Gerontol A Biol Sci Med Sci. 2010;65A:963–975.
   Web of Science ®Google Scholar
• Sharma N, Castorena CM, Cartee GD. Greater insulin sensitivity in calorie restricted rats occurs with unaltered circulating levels of several important myokines and cytokines. Nutr Metab (Lond). 2012;9:90.
   PubMed Web of Science ®Google Scholar
• Lane MA, Ingram DK, Roth GS. 2-Deoxy-D-glucose feeding in rats mimics physiologic effects of calorie restriction. J Anti Aging Med. 1998;1:327–337.
   Google Scholar
• Schulz TJ, Zarse K, Voigt A, et al. Glucose restriction extends caenorhabditis elegans life span by inducing mitochondrial respiration and increasing oxidative stress. Cell Metab. 2007;6:280–293.
   PubMed Web of Science ®Google Scholar
• Ingram DK, Roth GS. Glycolytic inhibition as a strategy for developing calorie restriction mimetics. Exp Gerontol. 2011;46:148–154.
   PubMed Web of Science ®Google Scholar
• Wang Q, Liang B, Shirwany NA, et al. 2-Deoxy-D-glucose treatment of endothelial cells induces autophagy by reactive oxygen species-mediated activation of the AMP-activated protein kinase. Xu A, editor. PLoS One. 2011;6:e17234.
   PubMed Web of Science ®Google Scholar
• Yang N-C, Song T-Y, Chen M-Y, et al. Effects of 2-deoxyglucose and dehydroepiandrosterone on intracellular NAD+ level, SIRT1 activity and replicative lifespan of human Hs68 cells. Biogerontology. 2011;12:527–536.
   PubMed Web of Science ®Google Scholar
• Minor RK, Smith DL Jr., Sossong AM, et al. Chronic ingestion of 2-deoxy-d-glucose induces cardiac vacuolization and increases mortality in rats. Toxicol Appl Pharmacol. 2010;243:332–339.
   PubMed Web of Science ®Google Scholar
• Sun W, Zeng C, Liao L, et al. Comparison of acarbose and metformin therapy in newly diagnosed type 2 diabetic patients with overweight and/or obesity. Curr Med Res Opin. 2016;32:1389–1396.
   PubMed Web of Science ®Google Scholar
• Harrison DE, Strong R, Allison DB, et al. Acarbose, 17-α-estradiol, and nordihydroguaiaretic acid extend mouse lifespan preferentially in males. Aging Cell. 2014;13:273–282.
   PubMed Web of Science ®Google Scholar
• Schnell O, Weng J, Sheu W-H-H, et al. Acarbose reduces body weight irrespective of glycemic control in patients with diabetes: results of a worldwide, non-interventional, observational study data pool. J Diabetes Complications. 2016;30:628–637.
   PubMed Web of Science ®Google Scholar
• Bartke A. The somatotropic axis and aging: mechanisms and persistent questions about practical implications. Exp Gerontol. 2009;44:372–374.
   PubMed Web of Science ®Google Scholar
• Junnila RK, List EO, Berryman DE, et al. The GH/IGF-1 axis in ageing and longevity. Nat Rev Endocrinol. 2013;9:366–376.
   PubMed Web of Science ®Google Scholar
• Sun LY, Spong A, Swindell WR, et al. Growth hormone-releasing hormone disruption extends lifespan and regulates response to caloric restriction in mice. eLife [Internet]. 2013 cited 2017 Feb 17;2. 2. Available from http://elifesciences.org/lookup/doi/10.7554/eLife.01098
   Google Scholar
• Laron Z. The GH-IGF1 axis and longevity. The paradigm of IGF1 deficiency. Hormones (Athens). 2008;7:24–27.
   PubMedGoogle Scholar
• Chanson P, Brue T, Delemer B, et al. Pegvisomant treatment in patients with acromegaly in clinical practice: the French ACROSTUDY. Ann Endocrinol (Paris). 2015;76:664–670.
   PubMed Web of Science ®Google Scholar
• Hardie DG. AMP-activated protein kinase: a cellular energy sensor with a key role in metabolic disorders and in cancer. Biochem Soc Trans. 2011;39:1–13.
   PubMed Web of Science ®Google Scholar
• Pimentel GD, Ropelle ER, Rocha GZ, et al. The role of neuronal AMPK as a mediator of nutritional regulation of food intake and energy homeostasis. Metabolism. 2013;62:171–178.
   PubMed Web of Science ®Google Scholar
• Xu J, Ji J, Yan X-H. Cross-Talk between AMPK and mTOR in Regulating Energy Balance. Crit Rev Food Sci Nutr. 2012;52:373–381.
   PubMed Web of Science ®Google Scholar
• Pernicova I, Korbonits M. Metformin—mode of action and clinical implications for diabetes and cancer. Nat Rev Endocrinol. 2014;10:143–156.
   PubMed Web of Science ®Google Scholar
• Owen MR, Doran E, Halestrap AP. Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Biochem J. 2000;348(Pt 3):607–614.
   PubMed Web of Science ®Google Scholar
• Garg G, Singh S, Singh AK, et al. Antiaging effect of metformin on brain in naturally aged and accelerated senescence model of rat. Rejuvenation Res [Internet]. 2017 cited 2017 Feb 17;20:173–182. Available from: http://online.liebertpub.com/doi/10.1089/rej.2016.1883
   PubMed Web of Science ®Google Scholar
• Barzilai N, Crandall JP, Kritchevsky SB, et al. Metformin as a tool to target aging. Cell Metab. 2016;23:1060–1065.
   PubMed Web of Science ®Google Scholar
• Drew DA, Cao Y, Chan AT. Aspirin and colorectal cancer: the promise of precision chemoprevention. Nat Rev Cancer. 2016;16:173–186.
   PubMed Web of Science ®Google Scholar
• Shiao J, Thomas KM, Rahimi AS, et al. Aspirin/antiplatelet agent use improves disease-free survival and reduces the risk of distant metastases in Stage II and III triple-negative breast cancer patients. Breast Cancer Res Treat. 2017;161:463–471.
   PubMed Web of Science ®Google Scholar
• Strong R, Miller RA, Astle CM, et al. Nordihydroguaiaretic acid and aspirin increase lifespan of genetically heterogeneous male mice. Aging Cell. 2008;7:641–650.
   PubMed Web of Science ®Google Scholar
• Din FVN, Valanciute A, Houde VP, et al. Aspirin inhibits mTOR signaling, activates AMP-activated protein kinase, and induces autophagy in colorectal cancer cells. Gastroenterology. 2012;142:1504–1515.e3.
   PubMed Web of Science ®Google Scholar
• Wan Q-L, Zheng S-Q, Wu G-S, et al. Aspirin extends the lifespan of Caenorhabditis elegans via AMPK and DAF-16/FOXO in dietary restriction pathway. Exp Gerontol. 2013;48:499–506.
   PubMed Web of Science ®Google Scholar
• Lamming DW, Ye L, Sabatini DM, et al. Rapalogs and mTOR inhibitors as anti-aging therapeutics. J Clin Investig. 2013;123:980–989.
   PubMed Web of Science ®Google Scholar
• Josse L, Xie J, Proud CG, et al. mTORC1 signalling and eIF4E/4E-BP1 translation initiation factor stoichiometry influence recombinant protein productivity from GS-CHOK1 cells. Biochem J. 2016;473:4651–4664.
   PubMed Web of Science ®Google Scholar
• Vellai T, Takacs-Vellai K, Zhang Y, et al. Genetics: influence of TOR kinase on lifespan in C. elegans. Nature. 2003;426:620–620.
   PubMed Web of Science ®Google Scholar
• Kapahi P, Zid BM, Harper T, et al. Regulation of lifespan in drosophila by modulation of genes in the TOR signaling pathway. Curr Biol. 2004;14:885–890.
   PubMed Web of Science ®Google Scholar
• Bjedov I, Toivonen JM, Kerr F, et al. Mechanisms of life span extension by rapamycin in the fruit fly drosophila melanogaster. Cell Metab. 2010;11:35–46.
   PubMed Web of Science ®Google Scholar
• Hansen M, Taubert S, Crawford D, et al. Lifespan extension by conditions that inhibit translation in Caenorhabditis elegans. Aging Cell. 2007;6:95–110.
   PubMed Web of Science ®Google Scholar
• Kaeberlein M. Regulation of yeast replicative life span by TOR and Sch9 in response to nutrients. Science. 2005;310:1193–1196.
   PubMed Web of Science ®Google Scholar
• Powers RW. Extension of chronological life span in yeast by decreased TOR pathway signaling. Genes Dev. 2006;20:174–184.
   PubMed Web of Science ®Google Scholar
• Robida-Stubbs S, Glover-Cutter K, Lamming DW, et al. TOR signaling and rapamycin influence longevity by regulating SKN-1/Nrf and DAF-16/FoxO. Cell Metab. 2012;15:713–724.
   PubMed Web of Science ®Google Scholar
• Harrison DE, Strong R, Sharp ZD, et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature [Internet]. 2009 cited 2017 Feb 17. Available from http://www.nature.com/doifinder/10.1038/nature08221
   Google Scholar
• Fok WC, Chen Y, Bokov A, et al. Mice fed rapamycin have an increase in lifespan associated with major changes in the liver transcriptome. Kaeberlein M, editor. PLoS One. 2014;9:e83988.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Bokov A, Gelfond J, et al. Rapamycin extends life and health in C57BL/6 Mice. J Gerontol A Biol Sci Med Sci. 2014;69A:119–130.
   Web of Science ®Google Scholar
• Neff F, Flores-Dominguez D, Ryan DP, et al. Rapamycin extends murine lifespan but has limited effects on aging. J Clin Investig. 2013;123:3272–3291.
   PubMed Web of Science ®Google Scholar
• Anisimov VN, Zabezhinski MA, Popovich IG, et al. Rapamycin increases lifespan and inhibits spontaneous tumorigenesis in inbred female mice. Cell Cycle. 2011;10:4230–4236.
   PubMed Web of Science ®Google Scholar
• Popovich IG, Anisimov VN, Zabezhinski MA, et al. Lifespan extension and cancer prevention in HER-2/neu transgenic mice treated with low intermittent doses of rapamycin. Cancer Biol Ther. 2014;15:586–592.
   PubMed Web of Science ®Google Scholar
• Laplante M, Sabatini DM. mTOR signaling in growth control and disease. Cell. 2012;149:274–293.
   PubMed Web of Science ®Google Scholar
• Mannick JB, Del Giudice G, Lattanzi M, et al. mTOR inhibition improves immune function in the elderly. Sci Transl Med. 2014;6:268ra179–268ra179.
   PubMed Web of Science ®Google Scholar
• Mahé E, Morelon E, Lechaton S, et al. Cutaneous adverse events in renal transplant recipients receiving sirolimus-based therapy. Transplantation. 2005;79:476–482.
   PubMed Web of Science ®Google Scholar
• McCormack FX, Inoue Y, Moss J, et al. Efficacy and Safety of Sirolimus in Lymphangioleiomyomatosis. New England J Med. 2011;364:1595–1606.
   PubMed Web of Science ®Google Scholar
• Johnston O, Rose CL, Webster AC, et al. Sirolimus is associated with new-onset diabetes in kidney transplant recipients. J Am Soc Nephrol. 2008;19:1411–1418.
   PubMed Web of Science ®Google Scholar
• Lamming DW, Ye L, Katajisto P, et al. Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity. Science. 2012;335:1638–1643.
   PubMed Web of Science ®Google Scholar
• Yang S-B, Lee HY, Young DM, et al. Rapamycin induces glucose intolerance in mice by reducing islet mass, insulin content, and insulin sensitivity. J Mol Med. 2012;90:575–585.
   PubMed Web of Science ®Google Scholar
• Liu Y, Diaz V, Fernandez E, et al. Rapamycin-induced metabolic defects are reversible in both lean and obese mice. Aging. 2014;6:742–754.
   PubMedGoogle Scholar
• Arriola Apelo SI, Neuman JC, Baar EL, et al. Alternative rapamycin treatment regimens mitigate the impact of rapamycin on glucose homeostasis and the immune system. Aging Cell. 2016;15:28–38.
   PubMed Web of Science ®Google Scholar
• Armanios M, Alder JK, Parry EM, et al. Short telomeres are sufficient to cause the degenerative defects associated with aging. Am J Hum Genet. 2009;85:823–832.
   PubMed Web of Science ®Google Scholar
• Boccardi V, Herbig U. Telomerase gene therapy: a novel approach to combat aging: Telomerase gene therapy. EMBO Mol Med. 2012;4:685–687.
   PubMed Web of Science ®Google Scholar
• Blackburn EH, Epel ES, Lin J. Human telomere biology: a contributory and interactive factor in aging, disease risks, and protection. Science. 2015;350:1193–1198.
   PubMed Web of Science ®Google Scholar
• Xu Y, Goldkorn A. Telomere and telomerase therapeutics in cancer. Genes. 2016;7:22.
   PubMed Web of Science ®Google Scholar
• Bernardes de Jesus B, Vera E, Schneeberger K, et al. Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer: TERT alone extends lifespan of adult/old mice. EMBO Mol Med. 2012;4:691–704.
   PubMed Web of Science ®Google Scholar
• Tomás-Loba A, Flores I, Fernández-Marcos PJ, et al. Telomerase reverse transcriptase delays aging in cancer-resistant mice. Cell. 2008;135:609–622.
   PubMed Web of Science ®Google Scholar
• Rufer N. Transfer of the human telomerase reverse transcriptase (TERT) gene into T lymphocytes results in extension of replicative potential. Blood. 2001;98:597–603.
   PubMed Web of Science ®Google Scholar
• Fauce SR, Jamieson BD, Chin AC, et al. Telomerase-based pharmacologic enhancement of antiviral function of human CD8+ T Lymphocytes. J Immunol. 2008;181:7400–7406.
   PubMed Web of Science ®Google Scholar
• Harley CB, Liu W, Blasco M, et al. A natural product telomerase activator as part of a health maintenance program. Rejuvenation Res. 2011;14:45–56.
   PubMed Web of Science ®Google Scholar
• Bernardes de Jesus B, Schneeberger K, Vera E, et al. The telomerase activator TA-65 elongates short telomeres and increases health span of adult/old mice without increasing cancer incidence. Aging Cell. 2011;10:604–621.
   PubMed Web of Science ®Google Scholar
• Le Saux CJ, Davy P, Brampton C, et al. A novel telomerase activator suppresses lung damage in a murine model of idiopathic pulmonary fibrosis. PLoS One. 2013;8:e58423.
   PubMed Web of Science ®Google Scholar
• Raguraman V, Subramaniam JR. Withania somnifera root extract enhances telomerase activity in the human hela cell line. Adv Biosci Biotechnol. 2016;07:199–204.
   Google Scholar
• Haendeler J. Antioxidants inhibit nuclear export of telomerase reverse transcriptase and delay replicative senescence of endothelial cells. Circ Res. 2004;94:768–775.
   PubMed Web of Science ®Google Scholar
• Dong XX, Hui ZJ, Xiang WX, et al. Ginkgo biloba extract reduces endothelial progenitor-cell senescence through augmentation of telomerase activity. J Cardiovasc Pharmacol. 2007;49:111–115.
   PubMed Web of Science ®Google Scholar
• Ravikumar B, Sarkar S, Davies JE, et al. Regulation of mammalian autophagy in physiology and pathophysiology. Physiol Rev. 2010;90:1383–1435.
   PubMed Web of Science ®Google Scholar
• Madeo F, Zimmermann A, Maiuri MC, et al. Essential role for autophagy in life span extension. J Clin Investig. 2015;125:85–93.
   PubMed Web of Science ®Google Scholar
• Alvers AL, Wood MS, Hu D, et al. Autophagy is required for extension of yeast chronological life span by rapamycin. Autophagy. 2009;5:847–849.
   PubMed Web of Science ®Google Scholar
• Morselli E, Maiuri MC, Markaki M, et al. Caloric restriction and resveratrol promote longevity through the Sirtuin-1-dependent induction of autophagy. Cell Death Dis. 2010;1:e10.
   PubMed Web of Science ®Google Scholar
• He L, Lu J, Yue Z. Autophagy in ageing and ageing-associated diseases. Acta Pharmacol Sin. 2013;34:605–611.
   PubMed Web of Science ®Google Scholar
• Hyun D-H, Hernandez JO, Mattson MP, et al. The plasma membrane redox system in aging. Ageing Res Rev. 2006;5:209–220.
   PubMed Web of Science ®Google Scholar
• De Grey ADNJ. The plasma membrane redox system: a candidate source of aging-related oxidative stress. Age. 2005;27:129–138.
   PubMedGoogle Scholar
• Pandey KB, Rizvi SI. Markers of oxidative stress in erythrocytes and plasma during aging in humans. Oxid Med Cell Longev. 2010;3:2–12.
   PubMed Web of Science ®Google Scholar
• Hyun D-H, Emerson SS, Jo D-G, et al. Calorie restriction up-regulates the plasma membrane redox system in brain cells and suppresses oxidative stress during aging. Proc Natl Acad Sci. 2006;103:19908–19912.
   PubMed Web of Science ®Google Scholar
• Rizvi SI, Jha R, Maurya PK. Erythrocyte plasma membrane redox system in human aging. Rejuvenation Res. 2006;9:470–474.
   PubMed Web of Science ®Google Scholar
• Rizvi SI, Pandey KB, Jha R, et al. Ascorbate recycling by erythrocytes during aging in humans. Rejuvenation Res. 2009;12:3–6.
   PubMed Web of Science ®Google Scholar
• Rizvi SI, Jha R, Pandey KB. Activation of erythrocyte plasma membrane redox system provides a useful method to evaluate antioxidant potential of plant polyphenols. Methods Mol Biol. 2010;594:341–348.
   PubMedGoogle Scholar
• Pandey KB, Rizvi SI. Resveratrol up-regulates the erythrocyte plasma membrane redox system and mitigates oxidation-induced alterations in erythrocytes during aging in humans. Rejuvenation Res. 2013;16:232–240.
   PubMed Web of Science ®Google Scholar
• Rizvi SI, Kumar D, Chakravarti S, et al. Erythrocyte plasma membrane redox system may determine maximum life span. Med Hypotheses. 2011;76:547–549.
   PubMed Web of Science ®Google Scholar
• Chakravarty S, Rizvi SI. Circadian modulation of human erythrocyte plasma membrane redox system by melatonin. Neurosci Lett. 2012;518:32–35.
   PubMed Web of Science ®Google Scholar
• Childs BG, Durik M, Baker DJ, et al. Cellular senescence in aging and age-related disease: from mechanisms to therapy. Nat Med. 2015;21:1424–1435.
   PubMed Web of Science ®Google Scholar
• Coppé J-P, Desprez P-Y, Krtolica A, et al. The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathology: Mech Dis. 2010;5:99–118.
   PubMed Web of Science ®Google Scholar
• Yosef R, Pilpel N, Tokarsky-Amiel R, et al. Directed elimination of senescent cells by inhibition of BCL-W and BCL-XL. Nat Commun. 2016;7:11190.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Tchkonia T, Pirtskhalava T, et al. The Achilles’ heel of senescent cells: from transcriptome to senolytic drugs. Aging Cell. 2015;14:644–658.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Tchkonia T, Fuhrmann-Stroissnigg H, et al. Identification of a novel senolytic agent, navitoclax, targeting the Bcl-2 family of anti-apoptotic factors. Aging Cell. 2016;15:428–435.
   PubMed Web of Science ®Google Scholar
• Chen HP, Zhao YT, Zhao TC. Histone deacetylases and mechanisms of regulation of gene expression. Crit Rev Oncog. 2015;20:35–47.
   PubMedGoogle Scholar
• Vaiserman AM, Pasyukova EG. Life extension in drosophila by histone deacetylase inhibitors. In Vaiserman AM, Moskalev AA, Pasyukova EG, editors. Life extension [Internet]. Cham: Springer International Publishing; 2015 cited 2017 Feb 18. p. 245–264. Available from http://link.springer.com/10.1007/978-3-319-18326-8_11
   Google Scholar
• Yoon S, Eom GH. HDAC and HDAC inhibitor: from cancer to cardiovascular diseases. Chonnam Med J. 2016;52:1.
   PubMedGoogle Scholar
• Wood JG, Rogina B, Lavu S, et al. Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature. 2004;430:686–689.
   PubMed Web of Science ®Google Scholar
• Daitoku H, Sakamaki J, Fukamizu A. Regulation of FoxO transcription factors by acetylation and protein–protein interactions. Biochim Biophys Acta Mol Cell Res. 2011;1813:1954–1960.
   PubMed Web of Science ®Google Scholar
• Price NL, Gomes AP, Ling AJY, et al. SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function. Cell Metab. 2012;15:675–690.
   PubMed Web of Science ®Google Scholar
• Chung S, Yao H, Caito S, et al. Regulation of SIRT1 in cellular functions: role of polyphenols. Arch Biochem Biophys. 2010;501:79–90.
   PubMed Web of Science ®Google Scholar
• Howitz KT, Bitterman KJ, Cohen HY, et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature. 2003;425:191–196.
   PubMed Web of Science ®Google Scholar
• Baur JA, Pearson KJ, Price NL, et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature. 2006;444:337–342.
   PubMed Web of Science ®Google Scholar
• Pearson KJ, Baur JA, Lewis KN, et al. Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span. Cell Metab. 2008;8:157–168.
   PubMed Web of Science ®Google Scholar
• Yang D-L, Zhang H-G, Xu Y-L, et al. Resveratrol inhibits right ventricular hypertrophy induced by monocrotaline in rats. Clin Exp Pharmacol Physiol. 2010;37:150–155.
   PubMed Web of Science ®Google Scholar
• Wu Z, Xu Q, Zhang L, et al. Protective effect of resveratrol against kainate-induced temporal lobe epilepsy in rats. Neurochem Res. 2009;34:1393–1400.
   PubMed Web of Science ®Google Scholar
• Khan MM, Ahmad A, Ishrat T, et al. Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage and dopamine depletion in rat model of Parkinson’s disease. Brain Res. 2010;1328:139–151.
   PubMed Web of Science ®Google Scholar
• Karuppagounder SS, Pinto JT, Xu H, et al. Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer’s disease. Neurochem Int. 2009;54:111–118.
   PubMed Web of Science ®Google Scholar
• Witte AV, Kerti L, Margulies DS, et al. Effects of resveratrol on memory performance, hippocampal functional connectivity, and glucose metabolism in healthy older adults. J Neurosci. 2014;34:7862–7870.
   PubMed Web of Science ®Google Scholar
• Bhatt JK, Thomas S, Nanjan MJ. Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus. Nutr Res. 2012;32:537–541.
   PubMed Web of Science ®Google Scholar
• Minor RK, Baur JA, Gomes AP, et al. SRT1720 improves survival and healthspan of obese mice. Scientific Rep [Internet]. 2011 cited 2017 May 7;1. 1. Available from http://www.nature.com/articles/srep00070
   Google Scholar
• Mitchell SJ, Martin-Montalvo A, Mercken EM, et al. The SIRT1 activator SRT1720 extends lifespan and improves health of mice fed a standard diet. Cell Rep. 2014;6:836–843.
   PubMed Web of Science ®Google Scholar
• Gong B, Pan Y, Vempati P, et al. Nicotinamide riboside restores cognition through an upregulation of proliferator-activated receptor-γ coactivator 1α regulated β-secretase 1 degradation and mitochondrial gene expression in Alzheimer’s mouse models. Neurobiol Aging. 2013;34:1581–1588.
   PubMed Web of Science ®Google Scholar
• Lau D, Ogbogu U, Taylor B, et al. Stem cell clinics online: the direct-to-consumer portrayal of stem cell medicine. Cell Stem Cell. 2008;3:591–594.
   PubMed Web of Science ®Google Scholar
• Zhongling F, Gang Z, Lei Y. Neural stem cells and Alzheimer’s disease: challenges and hope. Am J Alzheimer’s Dis Other Demen. 2009;24:52–57.
   PubMed Web of Science ®Google Scholar
• Zhao C, Deng W, Gage FH. Mechanisms and functional implications of adult neurogenesis. Cell. 2008;132:645–660.
   PubMed Web of Science ®Google Scholar
• Ho P-J, Yen M-L, Yet S-F, et al. Current applications of human pluripotent stem cells: possibilities and challenges. Cell Transplant. 2012;21:801–814.
   PubMed Web of Science ®Google Scholar
• Jackson KA, Majka SM, Wang H, et al. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Investig. 2001;107:1395–1402.
   PubMed Web of Science ®Google Scholar
• Lo B, Parham L. Ethical issues in stem cell research. Endocr Rev. 2009;30:204–213.
   PubMed Web of Science ®Google Scholar
• Rong Z, Wang M, Hu Z, et al. An effective approach to prevent immune rejection of human ESC-derived allografts. Cell Stem Cell. 2014;14:121–130.
   PubMed Web of Science ®Google Scholar